SMITH SCOTT THOMAS

Track

Insider profile

SMITH SCOTT THOMAS's trades of Ascendis Pharma A/S's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-02 2026-06-02
B Purchase
46,097 -2.6%
54.63
US$3,335,473 		46,097 -2.6% 54.63 US$3,335,473
2026-06-01 2026-05-29
B Purchase
22,823 +12.1%
274.21
US$3,670,388 		22,823 +12.1% 274.21 US$3,670,388
2026-03-06 2026-03-05
PrS Proposed sale
87,738
333.76
US$3,568,406 		87,738 333.76 US$3,568,406
2026-03-05 2026-03-05
PrS Proposed sale
10,000
240.00
US$2,400,000 		10,000 240.00 US$2,400,000
2026-03-02 2026-03-02
PrS Proposed sale
18,349
242.09
US$4,442,109 		18,349 242.09 US$4,442,109
2025-08-12 2025-08-12
PrS Proposed sale
10,000
192.57
US$1,925,734 		10,000 192.57 US$1,925,734
2025-03-04 2025-03-04
PrS Proposed sale
13,344
152.12
US$2,029,949 		13,344 152.12 US$2,029,949
2025-02-20 2025-02-20
PrS Proposed sale
10,000
154.27
US$1,542,671 		10,000 154.27 US$1,542,671
2024-12-10 2024-12-10
PrS Proposed sale
2,119
129.13
US$273,621 		2,119 129.13 US$273,621
2024-03-04 2024-03-01
PrS Proposed sale
6,900
150.00
US$1,035,000 		6,900 150.00 US$1,035,000
2024-02-16 2024-02-16
PrS Proposed sale
6,563
149.03
US$978,100 		6,563 149.03 US$978,100
2023-09-26 2023-09-26
PrS Proposed sale
8,437
95.05
US$801,905 		8,437 95.05 US$801,905